Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Grafnetter

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|November 1, 1971
Effect of Atromid-S on the activity of vascular enzymes in ratsO Mrhová, D Grafnetter, J Janda, et al.
Review of Czechoslovak Medicine|January 1, 1974
Prevalence of ischaemic heart disease in men aged 50-54 years; processing by the Guha methodH Geizerová, D Grafnetter, Z Hejl, et al.
Ceskoslovenska Gastroenterologie a Vyziva|June 1, 1975
[Cholesterol content of blood-lipd-reducting diets (author's transl)]J Válek, D Grafnetter, M Kohout, et al.
Casopis Lekaru Ceskych|July 4, 1975
[ Hyperlipidemia and hyperlipoproteinemia among the relatives of diabetic patients]J Válek, D Grafnetter, Z Slabochová, et al.
Cor Et Vasa|January 1, 1975
Some risk factors of ischaemic heart disease in the Prague male populationH Geizerova, M Santrocek, Z Hejl, et al.
Casopis Lekaru Ceskych|December 17, 1976
[Somatic features in hyperlipidaemic subjects (author's transl)]J Cerovská, J Válek, J Kaucká, et al.
Casopis Lekaru Ceskych|February 4, 1977
[The significance of uric acid as a risk factor in clinical atherosclerosis]J Válek, D Grafnetter, Z Slabochová, et al.
Vnitrni Lekarstvi|March 1, 1989
[Levels of HDL cholesterol and the HDL2 and HDL3 subfractions in newly detected type 2 diabetes]J Brunová, J Válek, D Grafnetter, et al.
Vnitrni Lekarstvi|May 1, 1978
[An unusual case of hyperlipoproteinemia type III manifestation]J Válek, D Grafnetter, M Englis, et al.
Vnitrni Lekarstvi|October 1, 1981
[Risk of death due to cardiovascular causes after myocardial infarct]J Hammer, J Válek, I Stolz, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|November 1, 1971
Effect of Atromid-S on the activity of vascular enzymes in ratsO Mrhová, D Grafnetter, J Janda, et al.
Review of Czechoslovak Medicine|January 1, 1974
Prevalence of ischaemic heart disease in men aged 50-54 years; processing by the Guha methodH Geizerová, D Grafnetter, Z Hejl, et al.
Ceskoslovenska Gastroenterologie a Vyziva|June 1, 1975
[Cholesterol content of blood-lipd-reducting diets (author's transl)]J Válek, D Grafnetter, M Kohout, et al.
Casopis Lekaru Ceskych|July 4, 1975
[ Hyperlipidemia and hyperlipoproteinemia among the relatives of diabetic patients]J Válek, D Grafnetter, Z Slabochová, et al.
Cor Et Vasa|January 1, 1975
Some risk factors of ischaemic heart disease in the Prague male populationH Geizerova, M Santrocek, Z Hejl, et al.
Casopis Lekaru Ceskych|December 17, 1976
[Somatic features in hyperlipidaemic subjects (author's transl)]J Cerovská, J Válek, J Kaucká, et al.
Casopis Lekaru Ceskych|February 4, 1977
[The significance of uric acid as a risk factor in clinical atherosclerosis]J Válek, D Grafnetter, Z Slabochová, et al.
Vnitrni Lekarstvi|March 1, 1989
[Levels of HDL cholesterol and the HDL2 and HDL3 subfractions in newly detected type 2 diabetes]J Brunová, J Válek, D Grafnetter, et al.
Vnitrni Lekarstvi|May 1, 1978
[An unusual case of hyperlipoproteinemia type III manifestation]J Válek, D Grafnetter, M Englis, et al.
Vnitrni Lekarstvi|October 1, 1981
[Risk of death due to cardiovascular causes after myocardial infarct]J Hammer, J Válek, I Stolz, et al.
Pageof 10